Ignite Creation Date:
2024-05-06 @ 1:09 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03945760
Status:
COMPLETED
Last Update Posted:
2023-12-05
First Post:
2019-04-26
Brief Title:
Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Healthy Adult Male Subjects
Sponsor:
Wright State Physicians
Organization:
Wright State Physicians
Study Overview
Official Title:
An Investigator Initiated Study to Evaluate the Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions In Healthy Adult Male Subjects
Status:
COMPLETED
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The treatment of allergic contact dermatitis ACD can be unsatisfactory and that other skin diseases such as atopic dermatitis have an increased likelihood of ACD improved systemic treatments are needed
This research study explores the effectiveness of Baricitinib in treating Delayed-Type Hypersensitivity allergic versus Irritant Skin reactions Subjects for this study need to be healthy males between the ages of 18 and 40 This study will evaluate this by injecting antigens as well as applying them on top of the skin to the forearm then measure the effects of Baricitinib by skin and blood testing
This research study explores the effectiveness of Baricitinib in treating Delayed-Type Hypersensitivity allergic versus Irritant Skin reactions Subjects for this study need to be healthy males between the ages of 18 and 40 This study will evaluate this by injecting antigens as well as applying them on top of the skin to the forearm then measure the effects of Baricitinib by skin and blood testing
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None